Back

Early vascular responses to abluminal biodegradable polymer-coated versus circumferential durable polymer-coated newer-generation drug-eluting stents in humans: a pathologic study

29 August 2022 (10:15 - 10:40)
Organised by:
Congress Presentation Part of: Predicting percutaneous coronary intervention outcomes Devices ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Yasuhito Kawagoe

St. Marianna University School of Medicine, Kawasaki (Japan)

2 More presentations in this session

Presentation thumbnail
Consenting practices in interventional cardiology: an analysis from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Doctor C. Rajkumar (London, GB)
Abstract Slides
Presentation thumbnail
Drug-eluting balloons and drug-eluting stents in the treatment of small vessel coronary artery disease: a systematic review and metanalysis of long-term clinical and angiographic outcomes.
Doctor G. Murphy (Dublin, IE)
Abstract Slides

Access the full session

Session thumbnail
Predicting percutaneous coronary intervention outcomes

The Event

Event poster

ESC Congress 2022

29 August 2022 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Vascular healing of Combo plus stents in patients with acute coronary syndrome
27 August 2023
thumbnail
Congress Presentation
Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices from Japan Post-Market Surveillance Study
1 September 2020
thumbnail
Congress Presentation
A novel therapeutic approach for coronary inflammation and lymphatic vessels using non-invasive low-intensity pulsed ultrasound in a porcine model with DES-induced coronary hyperconstricting responses
30 August 2020
thumbnail
Congress Presentation
Thirty-days versus standard duration of dual antiplatelet treatment after percutaneous coronary interventions: a systematic review and meta-analysis
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources